Cargando…
Inactivation of Plasmodium falciparum in whole blood using the amustaline and glutathione pathogen reduction technology
BACKGROUND: Risk of transfusion‐transmitted (TT) malaria is mainly associated with whole blood (WB) or red blood cell (RBC) transfusion. Risk mitigation relies mostly on donor deferral while a limited number of countries perform blood testing, both negatively impacting blood availability. This study...
Autores principales: | Sow, Cissé, Laughhunn, Andrew, Girard, Yvette A., Lanteri, Marion C., Amar El Dusouqui, Soraya, Stassinopoulos, Adonis, Grellier, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187285/ https://www.ncbi.nlm.nih.gov/pubmed/32129497 http://dx.doi.org/10.1111/trf.15734 |
Ejemplares similares
-
Robust inactivation of Plasmodium falciparum in red blood cell concentrates using amustaline and glutathione pathogen reduction
por: Sow, Cissé, et al.
Publicado: (2022) -
Preclinical safety assessment of pathogen reduced red blood cells treated with amustaline and glutathione
por: North, Anne K., et al.
Publicado: (2020) -
Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen‐reduction technology
por: Girard, Yvette A., et al.
Publicado: (2020) -
Effective inactivation of a wide range of viruses by pasteurization
por: Gröner, Albrecht, et al.
Publicado: (2017) -
Impact of cold storage on platelets treated with Intercept pathogen inactivation
por: Six, Katrijn R., et al.
Publicado: (2019)